Skip to main content
. 2018 Apr 4;13(4):e0193544. doi: 10.1371/journal.pone.0193544

Table 3. Adverse event frequencies.

Placebo PEG 3350 8 g PEG 3350 17 g
(n = 24) (n = 26) (n = 23)
# (%) of subjects with TEAEs 14 (58%) 15 (58%) 13 (57%)
# (%) of subjects with Grade 1 TEAEs 12 (50%) 12 (46%) 8 (35%)
# (%) of subjects with Grade 2 TEAEs 7 (29%) 7 (27%) 8 (35%)
# (%) of subjects with Grade 3 TEAEs 2 (8%) 3 (12%) 3 (13%)
# (%) subjects off study 0 (0%) 2(8%) 2 (9%)